Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)

NCT00095238 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT00095238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00095238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2002
Completion date
July 31, 2008
Enrollment
4,128 (actual)
Sites
229

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure